PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000850372.60201.c7 |
_version_ | 1797281299611779072 |
---|---|
author | B. Kahl J. Cohen R. Pillai V. Jayaprakash C. Wang M. Hahka-Kemppinen M. Kania P. Zinzani |
author_facet | B. Kahl J. Cohen R. Pillai V. Jayaprakash C. Wang M. Hahka-Kemppinen M. Kania P. Zinzani |
author_sort | B. Kahl |
collection | DOAJ |
first_indexed | 2024-03-07T16:55:33Z |
format | Article |
id | doaj.art-f72b261d0f444718918a6bd8f18b583e |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:55:33Z |
publishDate | 2022-06-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-f72b261d0f444718918a6bd8f18b583e2024-03-03T04:28:11ZengWileyHemaSphere2572-92412022-06-0161760176110.1097/01.HS9.0000850372.60201.c7202206003-01760PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMAB. Kahl0J. Cohen1R. Pillai2V. Jayaprakash3C. Wang4M. Hahka-Kemppinen5M. Kania6P. Zinzani71 Washington University School of Medicine, St Loius2 Emory University School of Medicine, Atlanta3 HUTCHMED International Corporation, Florham Park, United States of America3 HUTCHMED International Corporation, Florham Park, United States of America3 HUTCHMED International Corporation, Florham Park, United States of America3 HUTCHMED International Corporation, Florham Park, United States of America3 HUTCHMED International Corporation, Florham Park, United States of America4 University of Bologna Institute of Hematology, Bologna, Italyhttp://journals.lww.com/10.1097/01.HS9.0000850372.60201.c7 |
spellingShingle | B. Kahl J. Cohen R. Pillai V. Jayaprakash C. Wang M. Hahka-Kemppinen M. Kania P. Zinzani PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA HemaSphere |
title | PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA |
title_full | PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA |
title_fullStr | PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA |
title_full_unstemmed | PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA |
title_short | PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA |
title_sort | pb1880 a multicenter phase 1 study evaluating the safety and tolerability of hmpl 760 in patients with previously treated chronic lymphocytic leukemia small lymphocytic lymphoma or other non hodgkin lymphoma |
url | http://journals.lww.com/10.1097/01.HS9.0000850372.60201.c7 |
work_keys_str_mv | AT bkahl pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma AT jcohen pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma AT rpillai pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma AT vjayaprakash pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma AT cwang pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma AT mhahkakemppinen pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma AT mkania pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma AT pzinzani pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma |